# Study of an Extended Release (ER) Tablet, Single and Repeated Dosing

> **NCT00689039** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 94 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD1305
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00689039
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2010-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689039, "Study of an Extended Release (ER) Tablet, Single and Repeated Dosing". Retrieved via MORVS 2026-09-30 from https://api.morvs.ai/clinical/NCT00689039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*